Demetra Strengthens Spine Surgery Position with Maxxspine Acquisition

Demetra Acquires Maxxspine Innovative GmbH

On April 30, 2026, Demetra, an innovative and independent international medical company, announced the successful acquisition of Maxxspine Innovative GmbH. This acquisition significantly strengthens Demetra's prominent position in the world of spine surgery. Maxxspine has been a leader in advanced spinal solutions for over 20 years, recognized for its development and distribution of cutting-edge medical devices in the spinal market.

Based in Germany and founded in 2010, Maxxspine has established a strong presence in the German market while also extending its reach internationally. With this acquisition, Demetra will enhance its product portfolio related to spinal treatments and extend closer partnerships with surgeons and healthcare professionals in key European markets and beyond.

Demetra has a rich history of over 40 years, being a trusted partner to healthcare professionals across the globe. The introduction of innovative solutions in infection control, prosthetic fixation, orthobiology, and minimally invasive surgery has improved the lives of more than three million patients. The company continues to invest in innovation, talent, and sustainable growth through its established subsidiaries like Tecres, Osartis, and OsteoRemedies.

As part of the transaction, Osartis GmbH, a subsidiary of the Demetra Group, will take over all Global activities of Maxxspine and ensure a smooth integration process with the existing management and teams over the coming months. This integration aims to maintain continuity for clients and partners alike.

Volker Ludwig, CEO of Maxxspine Innovative, expressed his enthusiasm, stating, “Being a part of a solid and ambitious international group like Demetra provides the ideal platform to continue developing what I have built over the years. I take pride in our journey thus far and have confidence in what we can achieve together, respecting and promoting the trust and professionalism values of Maxxspine.”

Having provided innovative and personalized solutions in the spinal sector for over two decades, Maxxspine seeks to take a significant strategic step forward. The integration with Demetra will considerably enhance their capabilities, market reach, and robustness, which positions them favorably against global competitors, helping them strengthen their footing in this dynamic market, especially in fields like kyphoplasty.

Michele Perrino, CEO of Demetra, commented on the acquisition, saying, “The acquisition of Maxxspine perfectly aligns with Demetra's strategy to reinforce its presence in key European markets for spine surgery. By integrating highly specialized companies like Maxxspine, we enhance our ability to remain close to both surgeons and patients, securing our role as a trusted international partner in spinal care.”

About Demetra

Demetra is a global and independent healthcare group specializing in developing solutions for periprosthetic infection treatment and minimally invasive surgical solutions. Present in over 100 countries, Demetra is committed to enhancing patient care by investing in people, research, and sustainable innovation. Their growing lineup of patented technologies underlines their dedication to improving healthcare outcomes globally.

With the integration of Maxxspine, Demetra not only strengthens its market position but also opens new avenues for innovative spinal treatment solutions in the future.